- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | FDA committee proposes overhaul of perioperative lung cancer trials | ||
| Fr | EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage | ||
| Fr | FDA approves Sun Pharma's JAK inhibitor for alopecia | ||
| Fr | Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval | ||
| Fr | Inside the effort to rescue a rare disease gene therapy | ||
| Fr | Cue Biopharma downsizes to focus on autoimmune pipeline | ||
| Fr | Roche records 4% decline in H1 2024 net income | ||
| Fr | Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn | ||
| Fr | AbbVie's Q2 2024 net earnings drop to $1.37bn | ||
| Fr | EC conditionally approves Pfizer's haemophilia B gene therapy | ||
| Do | Ipsen outlines $461m for ex-US rights to Day One's glioma therapy | ||
| Do | Sandoz launches ustekinumab biosimilar in Europe | ||
| Do | ConSynance wins FDA designation for Prader-Willi syndrome therapy | ||
| Do | FDA agrees wider use of BioMarin's BRINEURA for CLN2 | ||
| Do | NICE recommends Boehringer's tenecteplase for NHS stroke care | ||
| Do | Dren Bio and Novartis link on bispecific antibodies for cancer | ||
| Do | MHRA approves Pfizer-BioNTech's Comirnaty JN.1 vaccine | ||
| Mi | The potential of 3D printing in drug development and delivery | ||
| Mi | Telix's prostate cancer imaging kit set for FDA review | ||
| Mi | New study suggests CAR-T therapy monitoring time could be slashed | ||
| Mi | AstraZeneca grows oncology portfolio with Pinetree's EGFR degrader | ||
| Mi | Standing ovation for Gilead as it boasts perfect efficacy in HIV PReP trial | ||
| Mi | Triastek and BioNTech to develop 3D-printed RNA therapeutics | ||
| Mi | BeiGene opens biologics facility in New Jersey, US | ||
| Mi | The new frontiers of supply chain disruption - and how pharma firms are responding |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
